Pricing
  1. US-listed companies
  2. FILANA THERAPEUTICS, INC.
  3. Financials
  4. Stockholders' equity

FILANA THERAPEUTICS, INC.【FLNA】

Market cap
$106.76M
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Dec 31, 2024146+5.99%
Dec 31, 2023137-39.58%
Dec 31, 2022228-10.39%
Dec 31, 2021254+175.40%
Dec 31, 202092+317.21%
Dec 31, 201922+12.59%
Dec 31, 201820+102.37%
Dec 31, 201710-47.96%
Dec 31, 201619-36.54%
Dec 31, 201529-26.69%
Dec 31, 201440-17.07%
Dec 31, 201348+267.71%
Dec 31, 201213-70.41%
Dec 31, 201144

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)